Annalise Donelon's Brain Tumor Diagnosis
Analysis based on 8 articles · First reported Jun 07, 2026 · Last updated Jun 08, 2026
This event highlights the challenges in accessing advanced medical treatments within national healthcare systems like the United Kingdom — National Health Service, potentially increasing demand for private and international healthcare services. It also underscores the need for increased investment in clinical trials and research within the biotechnology and pharmaceutical industries to develop new therapies for conditions like brain tumors.
Annalise Donelon, a 20-year-old chemical engineering student at Newcastle University, was diagnosed with a 5cm high-grade cancerous brain tumor after her persistent headaches were initially misdiagnosed as a B12 deficiency or exam stress. She underwent an 11-hour craniotomy at Salford Royal Hospital to remove most of the tumor, followed by six weeks of radiotherapy. Due to the uncertainty of the tumor's eradication and the unavailability of certain advanced treatments on the United Kingdom — National Health Service, Annalise Donelon and her family are fundraising £100,000 for international treatments, including molecular profiling in London, targeted molecular therapy in France, and immunotherapy in Germany. The Brain_Tumour_Charity has highlighted the urgent need for more clinical trials in the United Kingdom to provide accessible treatments. Annalise Donelon plans to switch her studies to biochemistry to contribute to research in genomic medicine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard